Novo sets sights on obesity market with diabetes drug.
Cormac
C
Sheridan
D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069450:Liraglutide / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D000069450:Liraglutide